Article
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
14 Jun 2023
Abstract excerpt
Alzheimer's disease (AD) pathology is thought to progress from normal cognition through preclinical disease and ultimately to symptomatic AD with cognitive impairment. Recent work suggests that the gut microbiome of symptomatic patients with AD has an altered taxonomic composition compared with that of healthy, cognitively normal control individuals. However, knowledge about changes in the gut microbiome before...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
